BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 8275387)

  • 1. Role of cytokines in the regulation of bone resorption.
    Roodman GD
    Calcif Tissue Int; 1993; 53 Suppl 1():S94-8. PubMed ID: 8275387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and local factors which affect osteoclast function.
    Mundy GR
    Int J Cell Cloning; 1992 Jul; 10(4):215-22. PubMed ID: 1645029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha.
    Tani-Ishii N; Tsunoda A; Teranaka T; Umemoto T
    J Dent Res; 1999 Oct; 78(10):1617-23. PubMed ID: 10520966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS; Flanagan AM
    Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation.
    Nishiyama K; Sugimoto T; Kaji H; Kanatani M; Kobayashi T; Chihara K
    Endocrinology; 1996 Jan; 137(1):35-41. PubMed ID: 8536635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
    J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling.
    Komarova SV; Smith RJ; Dixon SJ; Sims SM; Wahl LM
    Bone; 2003 Aug; 33(2):206-15. PubMed ID: 14499354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cell-matrix interactions in osteoclast differentiation.
    McHugh KP; Shen Z; Crotti TN; Flannery MR; Fajardo R; Bierbaum BE; Goldring SR
    Adv Exp Med Biol; 2007; 602():107-11. PubMed ID: 17966395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease.
    Neale SD; Schulze E; Smith R; Athanasou NA
    QJM; 2002 Apr; 95(4):233-40. PubMed ID: 11937650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast function in Paget's disease and multiple myeloma.
    Roodman GD
    Bone; 1995 Aug; 17(2 Suppl):57S-61S. PubMed ID: 8579899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts.
    Fuller K; Owens JM; Chambers TJ
    J Immunol; 1995 Jun; 154(11):6065-72. PubMed ID: 7751648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
    Kaji H; Sugimoto T; Kanatani M; Chihara K
    J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.
    Buchwald ZS; Kiesel JR; DiPaolo R; Pagadala MS; Aurora R
    PLoS One; 2012; 7(6):e38199. PubMed ID: 22701612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.